1-3 of 3
Xufeng Chen
Close
Sort by
Journal Articles

Modulation of RNA Splicing Enhances Response to BCL2 Inhibition in Acute Myeloid Leukemia

Eric Wang, Jose Mario Bello Pineda, Jessie Bourcier, Maximilian Stahl, Alexander V Penson, Isaac Wakiro, Michael E Singer, Daniel Cui, Caroline Erickson, Katherine Knorr, Robert Stanley, Xufeng Chen, Elizabeth A. McMillan, Carine Bossard, Iannis Aifantis, Robert K. Bradley, Omar Abdel-Wahab
Journal: Blood
Blood (2021) 138 (Supplement 1): 507.
https://doi.org/10.1182/blood-2021-146373
Published: 2021
Journal Articles

Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML

Clinical Trials & Observations
C. D. DiNardo, I. S. Tiong, A. Quaglieri, S. MacRaild, S. Loghavi, F. C. Brown, R. Thijssen, G. Pomilio, A. Ivey, J. M. Salmon, C. Glytsou, S. A. Fleming, Q. Zhang, H. Ma, K. P. Patel, S. M. Kornblau, Z. Xu, C. C. Chua, Xufeng Chen, P. Blombery, C. Flensburg, N. Cummings, I. Aifantis, H. Kantarjian, D. C. S. Huang, A. W. Roberts, I. J. Majewski, M. Konopleva, A. H. Wei
Journal: Blood
Blood (2020) 135 (11): 791–803.
https://doi.org/10.1182/blood.2019003988
Published: 2020
Includes: Supplemental data
Journal Articles

DNA Damage Repair Interference By WEE1 Inhibition with AZD1775 Overcomes Combined Azacitidine and Venetoclax Resistance in Acute Myeloid Leukmeia (AML)

Raoul Tibes, MD PhD, Diego Ferreira Coutinho, PhD, Michael Tuen Tuen, Xufeng Chen, PhD, Christina Glytsou, Ioannis Aifantis, Sergey Shmelkov, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2559.
https://doi.org/10.1182/blood-2019-130931
Published: 2019